Ursprung des Netzwerks ersten Grades von Xian Bu
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
SYN thesis med chem Pty Ltd.
 SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia.
1
| Private Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Xian Bu
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Medicines Development for Global Health Ltd
 Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
 Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Australien | 2 |
| China | 2 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 2 |
| Chairman | 1 |
| Founder | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Andrew Wilks | 3 |
